Next level
Respiratory training
AiroQur is designed to support people who want to strengthen their breathing performance and enhance their overall respiratory well-being.
The solution combines a training device, a connected mobile application, and a secure platform that allows professionals to follow users’ training activity and development over time.
Revolutionary treatment for COPD
Respiratory muscle training (RMT) is a 100% natural training method that helps you fight COPD symptoms.
Fight long-COVID with a scientifically proven method
Reclaim your life from the most common long-COVID symptoms with breathing training made simple.
Your natural asthma assistant
Respiratory muscle training (RMT) is the drug-free bronchial treatment that can help you fight off breathlessness, chest pain and wheezing.
Where innovation and wellness come together to nurture your overall well‑being.
Part of 15+ research studies
Through our sister company, Airofit, we have contributed to more than 15 research studies, and AiroQur is built directly on the data generated from this work. The underlying principles of AiroQur are supported by global meta‑studies and clinical trials evaluating RMT technologies. Across these studies, RMT has shown measurable improvements in respiratory function, including gains in lung capacity and breathing strength for individuals living with COPD, asthma, and long-COVID.
Build on the world’s largest database of breathing exercises (RMT)
AiroQur is powered by one of the largest breath‑training datasets in the world, encompassing nearly 50 million minutes of guided breathing training sessions and 7 million lung‑function tests. This rich and diverse dataset – spanning a wide range of ages, backgrounds, and health conditions – has provided us with deep insights into respiratory patterns and therapy. As a result, AiroQur continuously refines its algorithms, delivering breathing training that is personalized, adaptive, and effective.
High patient adherence
AiroQur supports high patient adherence by combining daily lung tests that measure both lung volume and respiratory strength with an app that provides real‑time feedback for each personalized training session. This integrated approach helps ensure effective training therapy while giving users a straightforward way to follow their progress over time.
AiroCare, our home therapy remote monitoring system, helps physicians and health care professionals manage training therapy and patient progression.
Built on data from 170,000+ Airofit users
"This has been a game-changer.
Being able to access rehabilitation anywhere, with customized advice from the app keeps me engaged.
I couldn't be more satisfied with my acquisition!"
Felix, 49
"After struggling with respiratory issues for years, I finally found a solution that works. The convenience and the results speak for themselves. Highly recommended!"
Mia, 52
"Initially skeptical, the device impressed me. Its sleek design and intuitive app enhance my routine, improving my breathing and well-being. Thanks!"
Anders, 57
What physicians say
I survived a triple-valve heart operation because I beforehand trained and improved my system with AiroQur.
AiroQur is currently world´s most important health solution for lung and heart patients.
Evidence-based technology
Our evidence-based breathing therapy and training technology has garnered the trust of over 170,000 training users. With proven results and a track record of success in improving overall respiratory health.
Get in touch
Have a question or need assistance? We’re here to help. Please fill out the form below.
Strengthen your respiratory portfolio with emerging technology
AiroQur is an under‑development connected respiratory muscle training system intended to support modern chronic‑care pathways. We work with distribution partners and healthcare professionals to explore how digital, remotely supported rehabilitation tools could contribute to future care models.
AiroQur is currently available in a number of countries outside the EU and the USA.
However, AiroQur is not currently CE‑marked and does not have FDA clearance. Similarly, AiroQur does not have regulatory approval in the UK, CA, AU & NZ.
Consequently, AiroQur is not available for clinical use in the European Union, the United States, the UK, Canada, Australia, or New Zealand.
All described functions or performance characteristics relate to a product in development and may change as evaluation and regulatory processes progress.
Contact us to discuss collaboration opportunities or to request information about our ongoing development and evaluation activities.
Titangade 9A
Copenhagen N, 2200
Denmark
Made in Denmark